Stocks Under F&O Ban: PG Electroplast, and Others
Under the futures and options (F&O) segment, three stocks were banned from trade on Thursday, 21 August, by the National Stock Exchange (NSE). The securities...
Author : Ali Waghbakriwala
Natco Pharma Launches Oral Drug: Shares Slump 1%
Shares of Natco Pharma Ltd were trading in the red and 1% lower on Wednesday, 20 August, despite the company announcing the launch of oral...
Online Gaming Ban Threatens 2 Lakh Jobs
A planned ban on online gaming threatens a rapidly expanding business that has become a source of jobs, tax income, and foreign investment in India....
Phoenix Mills Shares Gain 2% on Approval from CCI Stake Acquisition
Shares of Phoenix Mills Ltd were trading in the green and 2% higher on Tuesday, 20 August, after the Competition Commission of India (CCI) approved...
Hindustan Aeronautics Shares 3% as Cabinet Approves Rs 62,000 Crore Order
Shares of Hindustan Aeronautics Ltd (HAL) rose as much as 3.5% on 20 August after the state-run military giant was expected to receive one of...
Overnight Stock Market Movements: Key Developments
The benchmark indices Sensex and Nifty 50 are set to open lower on Wednesday as weakness in overnight global markets weighs on sentiment. Asian markets...
Stocks Under F&O Ban: Titagarh Rail, and Others
Under the futures and options (F&O) segment, two stocks were banned from trade on Wednesday, 20 August, by the National Stock Exchange (NSE). The securities...
Stocks in Focus: Hindustan Aeronautics, Indian Oil, and Others
The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading lower by 70 points at 24,963, indicating that the...
Sarda Energy Shares Surge 2% on Securing Bid for Coal Mine
Shares of Sarda Energy and Minerals Ltd were trading in the green and 2% higher on Tuesday, 19 August, after the company announced that it...
Alembic Pharma Shares Trade 2% Higher on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd increased 2% on Tuesday, 19 August 2025, on securing a final approval from the USFDA. Alembic Pharmaceuticals gained final approval...